Latest Breaking News On - Ral met inhibitor - Page 1 : comparemela.com

Merck, a leading science and technology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of once-daily oral TEPMETKO®

United statesMerck pressEuropean commissionDrug administrationGlobal head of development for the healthcareEuropean medicines agencyCommittee for medicinal products human useMedicinal productsHuman useDanny bar zoharGlobal headNew england journalLung cancerMerck press releasesMedia contactRal met inhibitor